Literature DB >> 20820992

Phosphorylation mechanisms in intensive care medicine.

Erica L Martin1, V Marco Ranieri.   

Abstract

INTRODUCTION: The phosphorylation states of proteins, lipids, carbohydrates, amino acids, and nucleotides control the mechanisms behind nearly all cellular functions. Therefore, not surprisingly, recent findings have shown that alterations in these phosphorylation pathways play a central role in the development and progression of many disease states. This review provides a brief summary of the function and activity of various phosphorylation mechanisms, outlines some of the major phosphorylation signaling cascades, and describes the role of these phosphorylation mechanisms in intensive care medicine.
METHODS: This article will comprise a comprehensive review of the literature in the context of intensive care medicine. Specifically, we will discuss the involvement of phosphorylation in the pathogenesis, diagnosis, and treatment of heart failure, myocardial infarction, stroke, respiratory failure, ventilation-induced lung injury, traumatic brain injury, acute organ failure, systemic sepsis, and shock.
CONCLUSION: Phosphorylation mechanisms clearly play an important role in many pathologies and treatment strategies of intensive care and therefore further understanding of these mechanisms may lead to the development of novel therapies and improved patient care.

Entities:  

Mesh:

Year:  2010        PMID: 20820992     DOI: 10.1007/s00134-010-2023-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  86 in total

Review 1.  Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.

Authors:  John J O'Shea; Massimo Gadina; Robert D Schreiber
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  Phosphorylation of the tumor necrosis factor receptor CD120a (p55) recruits Bcl-2 and protects against apoptosis.

Authors:  V Cottin; A A Van Linden; D W Riches
Journal:  J Biol Chem       Date:  2001-01-30       Impact factor: 5.157

Review 3.  Protein degradation by the ubiquitin-proteasome pathway in normal and disease states.

Authors:  Stewart H Lecker; Alfred L Goldberg; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2006-05-31       Impact factor: 10.121

4.  Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta.

Authors:  Masahiro Nishihara; Tetsuji Miura; Takayuki Miki; Jun Sakamoto; Masaya Tanno; Hironori Kobayashi; Yoshihiro Ikeda; Katsuhiko Ohori; Akari Takahashi; Kazuaki Shimamoto
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-03-24       Impact factor: 4.733

5.  TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-kappaB activation, and apoptosis.

Authors:  Yasunari Takada; Bharat B Aggarwal
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

6.  Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.

Authors:  Maurizio Salvadori; Maria Piera Scolari; Elisabetta Bertoni; Franco Citterio; Paolo Rigotti; Maria Cossu; Antonio Dal Canton; Giuseppe Tisone; Alberto Albertazzi; Francesco Pisani; Giampiero Gubbiotti; Gianbenedetto Piredda; Ghil Busnach; Vito Sparacino; Volker Goepel; Piergiorgio Messa; Pasquale Berloco; Domenico Montanaro; Pierfrancesco Veroux; Stefano Federico; Marta Bartezaghi; Giuseppe Corbetta; Claudio Ponticelli
Journal:  Transplantation       Date:  2009-11-27       Impact factor: 4.939

7.  IL-6 cytoprotection in hyperoxic acute lung injury occurs via PI3K/Akt-mediated Bax phosphorylation.

Authors:  Narasaiah Kolliputi; Aaron B Waxman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-17       Impact factor: 5.464

8.  Lyn, PKC-delta, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion.

Authors:  Ramya Chari; Soochong Kim; Swaminathan Murugappan; Archana Sanjay; James L Daniel; Satya P Kunapuli
Journal:  Blood       Date:  2009-07-08       Impact factor: 22.113

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  Role of extracellular signal-regulated protein kinase (ERK) in 17beta-estradiol-mediated attenuation of lung injury after trauma-hemorrhage.

Authors:  Jun-Te Hsu; Wen-Hong Kan; Chi-Hsun Hsieh; Mashkoor A Choudhry; Kirby I Bland; Irshad H Chaudry
Journal:  Surgery       Date:  2008-12-23       Impact factor: 3.982

View more
  2 in total

Review 1.  Year in review in Intensive Care Medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation.

Authors:  Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-01-20       Impact factor: 17.440

Review 2.  Research Progress on the Mechanism of Sepsis Induced Myocardial Injury.

Authors:  Cheng-Fei Bi; Jia Liu; Li-Shan Yang; Jun-Fei Zhang
Journal:  J Inflamm Res       Date:  2022-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.